Despite its exponential growth over the past few years, ‘FemTech’ is a relatively novel segment in the health technology market. In essence, it is innovation at the intersection of life sciences and technology to address health issues that solely or disproportionately affect women and address general health conditions that affect women differently to men, such as cardiovascular or oncological conditions.
On 11 June 2024, global accelerator FemTech Lab hosted its second women’s health tech conference – ‘Decoding the Future of Women’. This was held during London Tech Week and attendees included investors, corporate innovators and cutting- edge start-ups in the women’s health space. What follows are some of the key takeaways from the panel discussion on key investment trends and unicorns in the space, in addition to giving an overview of the FemTech sector more broadly.
